top of page
jumbo phages have unique
biological properties of high
potential to develop novel
technologies targeting top priority AMR pathogens
News & PRess
> SEP '24
phage therapy
Pioneering Solutions for Antibiotic-Resistant Infections
Kinzbio was recently featured in an article by BBC News, highlighting the company's significant advancements in the development and successful application of phage therapy in Uruguay.
Dr. Gaye from the Ministry of Public Health of Uruguay emphasized the "excellent potential" of this innovative therapy to address the growing challenge of antimicrobial resistance in the country and throughout the region.
.jpeg)
unleashing the potential of
Jumbo phages
together
Kinzbio fosters collaborations and partnerships with pharma leaders, clinical organizations, academic labs and funding agencies to help the company to accelerate the development of its jumbo phage platform and pipeline.
Kinzbio has an open communication channel with and is always seeking to hear from industry partners and funding institutions interested in joining efforts to keep developing applications based on the biology of jumbo phages.
BE IN
TOUCH
Please fill your contact details below:
Phage technologies for a
healthier world
ANtimicrobial
resistance is one
of the major global
health issues that
humanity is facing
every year millions
of lives are lost and
billions are spent in
prevention and
treatment of AMR
phages are natural
bacterial killers
that can be used to
combat AMR pathogens
News
Partnering
Contact
bottom of page